<DOC>
	<DOCNO>NCT00393393</DOCNO>
	<brief_summary>That Hylan G-F 20 may act protect cartilage expect degree degradation 12 month period subject moderate mark osteoarthritis knee</brief_summary>
	<brief_title>Effectiveness Study Hylan G-F 20 Preserve Cartilage Osteoarthritis Knee</brief_title>
	<detailed_description>Two course Hylan G-F 20 ( Synvisc ) administer intra-articular injection 6 monthly interval . MRI examination knee estimation cartilage volume prior treatment , second course 12 month 40 subject Grade 2/3 osteoarthritis knee . A 40 subject similar degree osteoarthritis knee receive Hylan G-F therapy assess MRI identical manner .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>grade 2 3 osteoarthritis knee age 18 80 pain score VAS &gt; 39 mm 100mm scale surgery prior 12 month significant valgus deformity recent trauma use opioid analgesia unstable medical condition recent corticosteroid injection morbid obesity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>knee</keyword>
	<keyword>hylan</keyword>
</DOC>